(Q41033555)

25 September 2017

title

Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

Neuroendocrine Effects of Apomorphine: Characterization of Response Patterns and Application to Schizophrenia Research (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

2 July 2023

1 reference

1 reference

J. Rotrosen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

B. Angrist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

S. Gershon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

J. Paquin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

L. Branchey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

M. Oleshansky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

F. Halpern

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

E. J. Sachar

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A540209

10 July 2022

language of work or name

English

0 references

publication date

1 November 1979

1 reference

full work available at URL

25 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S000712500004383X

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

British Journal of Psychiatry

2 July 2023

published in

1 reference

25 September 2017

volume

135

1 reference

25 September 2017

issue

5

0 references

page(s)

444-456

1 reference

A neuroendocrine study of supersensitivity in tardive dyskinesia

25 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Drugs, neurotransmitters, and schizophrenia

2 July 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Suppression of Human Growth Hormone Secretion by Melatonin and Cyproheptadine

2 July 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics

2 July 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effects of indomethacin and prostaglandin injections on plasma prolactin and growth hormone levels in rats

2 July 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Slight Effect ofl-Tryptophan on Growth Hormone Release in Normal Human Subjects1

2 July 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Neural regulation of growth hormone secretion

2 July 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Influence of adrenergic antagonists and apomorphine on prolactin release induced by serotonergic antagonists in the monkey

2 July 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion

2 July 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Naloxone inhibition of stress-induced increase in prolactin secretion

2 July 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Stress-induced growth hormone release: psychologic and physiologic correlates.

2 July 2023

17

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy

2 July 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Circadian Variation of Integrated Concentration of Growth Hormone in Children and Adults

2 July 2023

20

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

2 July 2023

21

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Postsynaptic supersensitivity in schizophrenia

2 July 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine-enkephalin

2 July 2023

23

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of methysergide and pimozide on apomorphine-induced growth hormone secretion in men

2 July 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Dopamine receptor alteration in schizophrenia: neuroendocrine evidence

2 July 2023

26

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Serum prolactin levels in unmedicated schizophrenic patients

2 July 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Evidence for dopamine receptor stimulation by apomorphine.

2 July 2023

29

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Apomorphine: Effect on Growth Hormone

2 July 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

2 July 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: neuroendocrine studies in normal men

2 July 2023

34

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Schizophrenia as a prostaglandin deficiency disease

2 July 2023

35

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Pattern of Plasma ACTH, hGH, and Cortisol During Menstrual Cycle

2 July 2023

36

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of ADP on PGE1Formation in Blood Platelets from Patients with Depression, Mania and Schizophrenia

2 July 2023

38

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors

2 July 2023

39

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of prostaglandin on the secretion of human growth hormone.

2 July 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

A Homologous Radioimmunoassay for Human Prolactin1

2 July 2023

41

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

The effects of serotonergic and adrenergic receptor antagonists on prolactin release in the monkey

2 July 2023

42

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Neuroendocrine studies with dopamine agonists in schizophrenia

2 July 2023

43

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Diagnostic Criteria for Use in Psychiatric Research

2 July 2023

44

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

2 July 2023

45

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of Clonidine on Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Thyroid-Stimulating Hormone in the Serum of Normal Men

2 July 2023

48

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

2 July 2023

50

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

The effect of prostaglandins on ox pituitary content of adenosine 3':5'-cyclic monophosphate and the release of growth hormone

2 July 2023

52

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats

2 July 2023

53

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Regulation of prolactin release by endogenous opiates

2 July 2023

54

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Increased Plasma Levels of Growth Hormone During Infusion of Propranolol

2 July 2023

55

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man

2 July 2023

56

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men

2 July 2023

57

1 reference

https://api.crossref.org/works/10.1192/BJP.135.5.444

2 July 2023

Identifiers

1 reference

release_hcxxydhnvvbcjfe63tgs5cxctu

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hcxxydhnvvbcjfe63tgs5cxctu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference